Prenetics Global Limited
PRE
$12.00
$1.1610.70%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 98.74% | -60.93% | 30.24% | 102.51% | -93.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 98.74% | -60.93% | 30.24% | 102.51% | -93.88% |
| Cost of Revenue | 145.57% | -89.66% | -24.13% | 102.45% | -90.19% |
| Gross Profit | 50.34% | -28.30% | 159.73% | 102.57% | -96.47% |
| SG&A Expenses | 103.33% | -49.14% | -22.78% | 133.61% | -51.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -70.25% | 58.78% | 30.55% | 536.29% | -290.83% |
| Total Operating Expenses | 71.00% | -49.69% | -21.41% | 111.93% | -71.34% |
| Operating Income | -58.72% | 44.77% | 38.49% | 81.96% | -174.00% |
| Income Before Tax | -70.57% | 51.76% | 32.47% | 62.65% | -5.20% |
| Income Tax Expenses | -67,586.36% | 93.06% | -254.40% | 100.19% | -100.33% |
| Earnings from Continuing Operations | -19.77% | 51.60% | 34.16% | 56.29% | 19.55% |
| Earnings from Discontinued Operations | 100.12% | 41.21% | -100.99% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 111.36% | 6.03% | -15.87% | -- | -- |
| Net Income | 3.57% | 50.83% | 17.60% | -1,154.41% | 8.91% |
| EBIT | -58.72% | 44.77% | 38.49% | 81.96% | -174.00% |
| EBITDA | -67.18% | 50.67% | 44.18% | 83.95% | -166.41% |
| EPS Basic | 8.84% | 57.37% | 29.02% | -141.53% | 63.61% |
| Normalized Basic EPS | -100.66% | -- | -- | 97.39% | -- |
| EPS Diluted | 12.61% | 55.65% | 29.09% | -143.42% | 63.60% |
| Normalized Diluted EPS | -100.66% | -- | -- | 97.39% | -- |
| Average Basic Shares Outstanding | 5.77% | 15.33% | 16.09% | 138.99% | 150.32% |
| Average Diluted Shares Outstanding | 5.77% | 15.33% | 16.09% | 138.99% | 150.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |